Design Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $78,190,000.
Profit Margin
| 2019 | 834 | -2.04M | -245443.65% |
|---|---|---|---|
| 2020 | 226 | -8.28M | -3663716.81% |
| 2021 | 0 | -35.53M | |
| 2022 | 0 | -58.61M | |
| 2023 | 0 | -66.86M |
DSGN Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 226 | 834 |
Cost of revenue | 537K | 466K | 129K | 5K | 1.65K |
Gross profit | -537K | -466K | -129K | -4.77K | -820 |
Operating exp. | |||||
Research and development | 57.06M | 48.61M | 24.77M | 6.06M | 1.65M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 78.19M | 67.59M | 35.83M | 8.33M | 1.90M |
Operating income | -78.19M | -67.59M | -35.83M | -8.33M | -1.90M |
Other income (expenses), net | 11.32M | 4.28M | 298K | 50K | -139K |
Income before tax | -66.86M | -63.30M | -35.53M | -8.28M | -2.04M |
Income tax expense | -1 | -4.69M | 0 | -201.29K | -1.90K |
Net income | -66.86M | -58.61M | -35.53M | -8.28M | -2.04M |
Earnings per share | |||||
Basic EPS | -1.19 | -1.05 | -0.77 | -0.3 | -0.07 |
Diluted EPS | -1.19 | -1.05 | -0.77 | -0.3 | -0.07 |
| Data source | Data source | Data source |